StockVS

ZeroStack Corp. (FLGC) 股票分析

金融服务

ZeroStack Corp.

$6.18

$-0.03 (-0.48%)

最后更新: 2026年3月31日

价格走势

分析

公司概述

ZeroStack Corp. (FLGC) operates as an AI-powered asset management entity within the Financial Services sector, specifically focusing on the distribution of pharmaceutical goods and medical cannabis products for various health indications, including cancer therapies. This positioning places the company in a niche intersection of technology and healthcare distribution, where it leverages decentralized AI capabilities alongside traditional supply chain operations. The firm maintains a market capitalization of $21.59 million and employs 64 individuals to execute its business strategy. With a trailing twelve-month revenue of $57.61 million, the company's scale suggests a mid-tier presence in its specific distribution verticals, indicating that while it has achieved significant top-line traction, its market cap remains relatively modest compared to large-cap financial peers, reflecting its specialized industry focus and current profitability challenges.

财务健康

The company reported total revenue of $57.61 million for the trailing twelve months, yet this generated a net income loss of $15,921,000, revealing a substantial gap between top-line generation and bottom-line profitability that points to high operational expenses or significant one-time costs. This loss corresponds with an EBITDA of $-13,713,000, highlighting that the business is currently burning cash at the operational level before financing costs. Free cash flow stands at $-4,575,625, which indicates limited financial flexibility and a reliance on external capital or existing cash reserves to fund operations and growth initiatives. The gross margin is 21.0%, suggesting moderate pricing power or cost of goods control, but this is eroded by operating expenses to result in an operating margin of -33.5% and a profit margin of -27.7%. The balance sheet holds $13.10 million in cash against $3.25 million in debt, providing a net cash position, although the debt-to-equity ratio of 5.00 indicates a highly leveraged capital structure relative to shareholders' equity. Despite the leverage, the current ratio of 2.08 suggests the company possesses sufficient short-term liquid assets to cover its short-term liabilities comfortably. However, the return on equity is -45.3% and the return on assets is -17.5%, metrics that reveal that management is currently generating negative returns on the capital deployed, signaling a need to improve cost efficiency or find higher-yielding revenue streams to restore profitability.

估值评估

The valuation metrics present a complex picture, with a P/E ratio (TTM) listed as N/A due to the lack of net income, while the forward P/E is -8.52, implying that future earnings are not expected to turn positive immediately based on current models. The price-to-book ratio is 0.10, indicating that the stock trades at a significant discount to its book value, which often suggests market skepticism regarding the quality of the company's assets or its ability to generate future earnings from them. Alternative valuation measures such as the price-to-sales ratio of 0.37 and an EV/EBITDA of 0.08 further underscore that the market prices the stock at a fraction of its sales and earnings potential, reflecting high risk perceptions. The 52-week trading range spans from a low of $5.86 to a high of $47.00, meaning the current implied valuation sits well below the 52-week high, highlighting significant volatility and potential downside risk or speculative opportunity relative to recent peaks. The beta value is 1.90, which indicates that the stock's price volatility is nearly twice that of the broader market, suggesting that price movements will likely be amplified during periods of market turbulence.

Growth & Income

Revenue growth year-over-year is 34.7%, demonstrating strong top-line expansion, while earnings growth is N/A because the company is currently unprofitable, meaning revenue expansion has not yet translated into bottom-line gains at this stage. As a non-dividend payer, the company reports a dividend yield of N/A and a payout ratio of 0.0%, indicating that all earnings, or in this case losses, are being retained within the company rather than distributed to shareholders, which is a common strategy for growth-oriented firms attempting to fund operations. The absence of a dividend yield confirms that the company reinvests its resources back into the business to support its AI development and distribution network rather than providing income to investors. Overall, the growth and income profile is characterized by aggressive revenue expansion coupled with significant losses and no current income distribution, creating a high-risk, high-reward dynamic typical of early-stage or turnaround financial service companies.

同行比较

ZeroStack Corp. (FLGC) 在资产管理行业运营。以下是其与市值最接近的同行的比较:

公司 代码 市值 市盈率
ZeroStack Corp. FLGC $21.59M N/A
BlackRock, Inc. BLK $167.25B 27.1
Blackstone Inc. BX $144.37B 30.3
Brookfield Corporation BN.TO $142.06B 89.6

资产管理行业平均市盈率为28.6倍。ZeroStack Corp.的市盈率为N/A。

本分析由AI生成,仅供参考,不构成投资建议。数据可能存在延迟或不准确。在做出投资决策之前,请务必进行自己的研究并咨询合格的财务顾问。

关于ZeroStack Corp.

Flora Growth Corp. operates as an AI-powered asset management company focused on providing decentralized AI. In addition, it engages in the distribution of pharmaceutical goods and medical cannabis products to treat a range of health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. Flora Growth Corp. was incorporated in 2019 and is headquartered in Fort Lauderdale, Florida.

公司简介以英文显示。

访问官网 →

关键指标

市值
$21.59M
市盈率
N/A
52周最高
$47.00
52周最低
$5.86
平均成交量
98.16K
Beta系数
1.90

数据由Yahoo Finance通过yfinance提供。每日更新。

公司信息

交易所
NASDAQ
国家
United States
员工数
64